Related Experiment Videos

Why and how to use insulin therapy earlier in the management of type 2 diabetes

Luigi Meneghini1

  • 1Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, FL 33136, USA. Lmeneghi@med.miami.edu

Southern Medical Journal
|March 3, 2007
PubMed

Insights

Most type 2 diabetes patients struggle with blood sugar control, risking serious complications. Early insulin therapy, aided by new analogs and delivery systems, can improve glycemic control and prevent long-term diabetes issues.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes management often involves inadequate glycemic control with existing therapies.
  • Suboptimal control leads to severe complications like retinopathy, nephropathy, neuropathy, and cardiovascular disease, increasing mortality risk.
  • Most patients eventually require insulin therapy for effective hyperglycemia management.

Purpose of the Study:

  • To highlight the benefits of earlier insulin initiation in type 2 diabetes.
  • To discuss barriers to insulin therapy adoption.
  • To explore how advancements in insulin analogs and delivery systems can overcome these barriers.

Main Methods:

  • Review of current treatment paradigms for type 2 diabetes.
  • Analysis of factors contributing to delayed insulin initiation.
  • Examination of novel insulin formulations and delivery technologies.

Main Results:

  • Inadequate glycemic control is prevalent in type 2 diabetes.
  • Delayed insulin use is common due to patient and physician concerns.
  • New insulin analogs and delivery systems show promise in improving treatment adherence and efficacy.

Conclusions:

  • Early insulin therapy is crucial for optimal glycemic control and complication prevention in type 2 diabetes.
  • Technological advancements are making insulin therapy more manageable.
  • Addressing patient concerns and simplifying regimens can facilitate wider insulin adoption.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...